Emerging in the field of obesity management, retatrutide is a distinct method. Unlike many current medications, retatrutide works as a double agonist, at once targeting both GLP peptide-1 (GLP-1) and glucose-sensitive insulinotropic polypeptide (GIP) sensors. This dual engagement promotes various beneficial effects, including improved glucose contr… Read More